ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder.
The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...
According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...
Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...
A board-certified sleep medicine specialist reviews the history of wearable sleep trackers and explains how clinicians ...
Taking a GLP-1 may help treat sleep apnea since obesity is one of many factors that increases your likelihood of the sleep ...
Considering the effect of poor sleep on the individual as well as on society and the economy, it is hardly surprising sleep ...
A new survey published today reveals that 70% of women report that their sleep is impacting their mental health, while a ...
If you are getting enough sleep at night consistently but are still not sleeping well or waking up feeling rested, it may be ...
Tom Castaneda from South Texas Health Systems discusses Sleep apnea on the upcoming episode of STHS TV on NBC 23. This ...
Medical conditions that deprive the testes of oxygen, such as sleep apnea, may be contributing to the decline in male fertility observed over the past 50 years, a new study suggests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback